1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety of the natural killer (NK) cell-targeted anti-KIR antibody, lirilumab (liri), in combination with nivolumab (nivo) or ipilimumab (ipi) in two phase 1 studies in advanced refractory solid tumors
    Meeting Abstract

    Segal, N. H.; Infante, J. R.; Sanborn, R. E.; Gibney, G. T.; Lawrence, D. P.; Rizvi, N.; Leidner, R.; Gajewski, T. F.; Bertino, E.; Sharfman, W. H.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Updated safety and efficacy of durvalumab (MEDI4736), an anti-PD-L 1 antibody, in patients from a squamous cell carcinoma of the head and neck (SCCHN) expansion cohort
    Meeting Abstract

    Segal, N. H.; Ou, S. H. I.; Balmanoukian, A. S.; Massarelli, E.; Brahmer, J. R.; Weiss, J.; Schoffski, P.; Antonia, S. J.; Massard, C.; Zandberg, D. P.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy and circulating tumor DNA (ctDNA) analysis of the BRAF inhibitor dabrafenib (D), MEK inhibitor trametinib (T), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E-mutated (BRAFm) metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Corcoran, R. B.; Andre, T.; Yoshino, T.; Bendell, J. C.; Atreya, C. E.; Schellens, J. H. M.; Ducreux, M. P.; McRee, A.; Siena, S.; Middleton, G.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with metastatic colorectal cancer (CRC) harboring NRAS mutations
    Meeting Abstract

    Braghiroli, M. I.; Chou, J. F.; Hechtman, J. F.; Capanu, M.; Cercek, A.; Yaeger, R.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1/2 study of the safety and clinical activity of durvalumab in patients with non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Antonia, S. J.; Brahmer, J. R.; Khleif, S.; Balmanoukian, A. S.; Ou, S. H. I.; Gutierrez, M.; Kim, D. W.; Kim, S. W.; Ahn, M. J.; Leach, J.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Is it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?
    Journal Article

    Teo, M. Y.; O'Reilly, E. M.
    Journal of Gastrointestinal Oncology (2016)

    Fulltext@MSK | Save
  • The genomics and therapeutics of HER2-positive gastric cancer-from trastuzumab and beyond
    Journal Article

    Kelly, C. M.; Janjigian, Y. Y.
    Journal of Gastrointestinal Oncology (2016)

    Fulltext@MSK | Save
  • Building a comprehensive educational model for nurse practitioner students in geriatric oncology
    Meeting Abstract

    McMillan, S. S.; Shahrokni, A.
    Gerontologist (2016)

    Fulltext@MSK | Save
  • Detection of IDH1 mutations in circulating free DNA in patients with cholangiocarcinoma
    Meeting Abstract

    Lowery, M. A.; You, D.; Samoila, A.; Peerschke, E.; Viale, A.; Patel, R.; Selcuklu, D.; Rusek, M.; Cercek, A.; Kemeny, N.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save